Evidence map›Paper›PMID 32735794›Full record

ArticleActa tropica2020

Malaria in Sundargarh district, Odisha, India: Epidemiological and behavioral aspects from surveys.

Anna Maria van Eijk, Sandhya Choubey, Punam Barla, Mohammed A Haque, P Nandini, Subrata Acharya, Steven A Sullivan, Sanjib Mohanty, Sanghamitra Satpathi, Jane M Carlton

Open access · hybridAbstract read
In one paragraph

Article in Acta tropica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Anna Maria van EijkCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY 10003, USA.
Sandhya ChoubeyJigyansha, International Center of Excellence for Malaria Research, Sector 1 Health Center, Rourkela, Odisha, India.
Punam BarlaJigyansha, International Center of Excellence for Malaria Research, Sector 1 Health Center, Rourkela, Odisha, India.
Mohammed A HaqueJigyansha, International Center of Excellence for Malaria Research, Sector 1 Health Center, Rourkela, Odisha, India.
P NandiniJigyansha, International Center of Excellence for Malaria Research, Sector 1 Health Center, Rourkela, Odisha, India.
Subrata AcharyaJigyansha, International Center of Excellence for Malaria Research, Sector 1 Health Center, Rourkela, Odisha, India.
Steven A SullivanCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY 10003, USA.
Sanjib MohantyJigyansha, International Center of Excellence for Malaria Research, Sector 1 Health Center, Rourkela, Odisha, India.
Sanghamitra SatpathiJigyansha, International Center of Excellence for Malaria Research, Sector 1 Health Center, Rourkela, Odisha, India.
Jane M CarltonCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY 10003, USA. Electronic address: jane.carlton@nyu.edu.
New York University · US

Funding

Using Next-Generation Genomics to Study Antimalarial Drug Resistance in IndiaU19AI089676 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARLTON, JANE M · 2010 to 2023
$22.6M
NIAID NIH HHS U19 AI089676
6 · The paper itself

Abstract

To characterize malaria and assist in prevention efforts, we conducted a series of epidemiological studies in Sundargarh district, India, as part of an NIH-funded International Center of Excellence for Malaria Research. In a published survey around Rourkela in 2013-2014 (N = 1307), malaria prevalence was found to be 8.3%. Using these data, villages were divided into low (<2%), medium (2-10%) and high (>10%) malaria prevalence, and risk factors assessed by type of village. In the six low malaria villages, four persons were positive by PCR; in the four medium malaria villages, prevalence was 7% (35 infections, 7 P. vivax); and in the three high malaria villages, prevalence was 21% (62 infections, 10 P. vivax and 5 mixed with P. vivax and P. falciparum). A total of 30.6% infections were submicroscopic and 40.6% were asymptomatic. Our analyses showed that the rainy season and male gender were risk factors for malaria; in high malaria villages, young age was an additional risk factor, and indoor and outdoor spraying was protective compared to no spraying. We undertook a subsequent behavioral survey in four of the medium and high malaria villages in 2017 to investigate the behavioral aspects of malaria risk. Among 500 participants in 237 households, adult men (15+ years) were more likely to be outside in the evening (34.5% vs. 7.9% among adult women 15+ years and 0.7% among children, p < 0.001), or to sleep outside (7.5% vs. 0.5% and 0%, respectively, p < 0.001). Although women were more likely to get up before 6 a.m. (86.6%, vs. 70.5% among men, 50.7% among children, p < 0.001), men were more likely to be outside in the early morning (77.6% among men, 11.2% among women, and 11.1% among children, p < 0.001). More children used insecticide treated nets the previous night (73.4%) than men (45.6%) or women (39.6%), and repellents were used by 29.5% of 234 households (insecticide creams were not used at all). Malaria control and elimination in India will need local approaches, and the promotion of repellent cream use by at-risk groups could be further explored in addition to mass-screen or treat programs in high-risk villages.

Indexed as

AdolescentAdultChildChild, PreschoolDelivery of Health CareFamily CharacteristicsFemaleHumansIndiaInsecticidesInsect RepellentsMalaria, FalciparumMalaria, VivaxMaleMiddle AgedPrevalenceInsecticidesInsect RepellentsMalaria risk factorsMosquito controlPlasmodium falciparumPlasmodium vivax

Identifiers

PMID32735794
PMCPMC7494530
OpenAlexW3045932973

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.